1. Irm LLC (9 from 151 patents)

2. Other (5 from 832,843 patents)

3. Novartis Ag (2 from 3,923 patents)

4. Ligand Pharmaceuticals, Inc. (2 from 134 patents)

5. Eli Lilly and Company (1 from 4,446 patents)

1. 10954233 - Compounds and compositions as inhibitors of endosomal toll-like receptors

2. 9440957 - Compounds and compositions for modulating EGFR Activity

3. 8957081 - Compounds and compositions as protein kinase inhibitors

4. 8722692 - Compounds and compositions as Syk kinase inhibitors

5. 8592432 - Compounds and compositions as protein kinase inhibitors

6. 8518931 - Compounds and compositions as kinase inhibitors

7. 8399450 - Compounds and compositions as protein kinase inhibitors

8. 8377921 - Compounds and compositions as protein kinase inhibitors

9. 8372858 - Compounds and compositions as protein kinase inhibitors

10. 8258156 - Compounds and compositions as modulators of GPR119 activity

11. 8153635 - Compounds and compositions as modulators of GPR119 activity

12. 8039479 - Compounds and compositions as protein kinase inhibitors

13. 7807841 - Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors

14. 7348359 - Retinoid X receptor modulators

15. 6825222 - Modulators of peroxisome proliferator activated receptors